# Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development

> **NCT02639676** · — · COMPLETED · sponsor: **Indiana University** · enrollment: 292 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **OTHER:** Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections

## Key facts

- **NCT ID:** NCT02639676
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-11
- **Primary completion:** 2020-11-17
- **Final completion:** 2020-11-17
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2022-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02639676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02639676, "Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02639676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*